Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma

Immune checkpoint inhibitors (ICI) have dramatically changed the treatment of metastatic renal cell carcinoma (mRCC). Although many studies have reported biomarkers as predicting the efficacy of ICI in mRCC, they remain controversial and have challenges to apply in real-world practice. We evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazama, Akira, Bilim, Vladimir, Tasaki, Masayuki, Anraku, Tsutomu, Kuroki, Hiroo, Shirono, Yuko, Murata, Masaki, Hiruma, Kaede, Tomita, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701769/
https://www.ncbi.nlm.nih.gov/pubmed/36437290
http://dx.doi.org/10.1038/s41598-022-24437-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701769/
https://www.ncbi.nlm.nih.gov/pubmed/36437290
http://dx.doi.org/10.1038/s41598-022-24437-6

Ejemplares similares